Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Virology|June 4, 2014
Multi-parameter exploration of HIV-1 virus-like particles as neutralizing antibody immunogens in guinea pigs, rabbits and macaquesTommy Tong, Ema T Crooks, Keiko Osawa, et al.
Plos Pathogens|August 7, 2023
Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoproteinTommy Tong, Alessio D'Addabbo, Jiamin Xu, et al.
Retrovirology|February 5, 2013
M48U1 CD4 mimetic has a sustained inhibitory effect on cell-associated HIV-1 by attenuating virion infectivity through gp120 sheddingPhilippe Selhorst, Katrijn Grupping, Tommy Tong, et al.
Glycobiology|August 8, 2024
Impact of glycan depletion, glycan debranching and increased glycan charge on HIV-1 neutralization sensitivity and immunogenicityAlessio D'Addabbo, Tommy Tong, Emma T Crooks, et al.
Urologic Oncology|November 28, 2016
Vitamin K epoxide reductase expression and prostate cancer riskBen Yi Tew, Sumanta K Pal, Miaoling He, et al.
Plos One|August 31, 2013
A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1Johannes S Gach, Heribert Quendler, Tommy Tong, et al.
Virology|March 11, 2017
Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody inductionEma T Crooks, Keiko Osawa, Tommy Tong, et al.
Plos One|July 11, 2013
Comparative Immunogenicity of Evolved V1V2-Deleted HIV-1 Envelope Glycoprotein TrimersIlja Bontjer, Mark Melchers, Tommy Tong, et al.
Molecular Cancer Research : MCR|September 4, 2014
RNA-seq reveals aurora kinase-driven mTOR pathway activation in patients with sarcomatoid metastatic renal cell carcinomaSumanta K Pal, Miaoling He, Tommy Tong, et al.
Nature Microbiology|July 5, 2016
HIV-host interactome revealed directly from infected cellsYang Luo, Erica Y Jacobs, Todd M Greco, et al.
Pageof 3